Amyotrophic Lateral Sclerosis provides outstanding coverage of research in a wide range of issues related to motor neuron diseases, especially ALS (Lou Gehrig's disease) and spinal muscular atrophies. The journal also covers related disorders of the motor system, when relevant to these core diseases. Amyotrophic Lateral Sclerosis aims to disseminate information on new developments in the pathogenesis and management of motor neuron disease, and enhance awareness of these devastating and often under-recognised disorders.

The Editors encourage submission of original research, case reports and short reports on all aspects of ALS, including basic science, genetics, new treatments, clinical trials, epidemiology, clinical neurophysiology, and other clinical and scientific aspects.

Features include:

• In-depth reviews
• Original research
• Basic science
• Epidemiology
• Clinical trials
• Care issues
• Ethics and legal issues
• Health economics
• Case reports
• Point-counterpoint debate
• Correspondence
• Book reviews
• ALS centre reports